The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cadelius 600 mg / 2000 IU orodispersible tablets

Italfarmaco S.A.PA2102/002/002

Main Information

Trade NameCadelius 600 mg / 2000 IU orodispersible tablets
Active SubstancesCalcium carbonate
Dosage FormOrodispersible tablet
Licence HolderItalfarmaco S.A.
Licence NumberPA2102/002/002

Group Information

ATC CodeA12AX Calcium, combinations with vitamin D and/or other drugs


License statusAuthorised
Licence Issued25/08/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back